Founded in 1999, PELVIPHARM is a spin-off from the University of Versailles-Saint-Quentin-en-Yvelines (France) relying on multi-disciplinary talents (medical doctor, pharmaco-economist, veterinarian, pharmacists and PhDs) who deliver both high quality academic standards and reliable contract research services : Preclinical studies based on validated efficacy models including delivery of protocol development, study conduct, report, communication and peer-reviewed publication.Guidance for selection of new chemical entities including testing with targeted assays according to potential mechanisms of action.Identification of new properties or attributes supporting differentiation of medications within the class or between classes.Advice in clinical development for new therapeutic indications or enhancements to address unmet medical need or significant commercial opportunities. PELVIPHARM has leading scientific and medical capabilities from unique expertise and experience in pathophysiology, pharmacology, clinical research and medical practice across a range of therapeutic areas including urology (BPH, OAB, NDO, SCI, SUI, IC …), sexual medicine (ED, PE, FSD …) and cardiovascular (Hypertension, Atherosclerosis, Myocardial Infarction …), metabolism and eating disorders (Metabolic Syndrome, Obesity, Diabetes ...)
Phone: 331, 704, 293, 39
Fax: 331, 704, 295, 10
E-mail: contact@pelvipharm.com
Web: https://www.pelvipharm.com
Add：Faculté de Médecine - Université de Versailles St Quentin en, Yvelines,2 Avenue de la Source de la Bièvre,78180 Montigny-Le-Bretonneux -
想要下载更多资料，请您添加微信了解详情！
微信号：csco2022
公众号：康安医药咨询
